Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Akr1c18 |  |
NM_134066 |
aldo-keto reductase family 1, member C18 (Akr1c18), mRNA [NM_134066] |
KLA | .97 |
.98 |
1.01 |
1.09 |
1.09 |
.93 |
1.02 |
| ATP | 1.02 |
1.08 |
1.03 |
1.00 |
1.07 |
1.69 |
2.33 |
| KLA/ATP | 1.04 |
.89 |
1.17 |
1.07 |
1.09 |
1.19 |
1.35 |
|
Akr1d1 |  |
NM_145364 |
aldo-keto reductase family 1, member D1 (Akr1d1), mRNA [NM_145364] |
KLA | 1.00 |
1.04 |
1.01 |
1.02 |
.98 |
1.01 |
.97 |
| ATP | 1.01 |
.99 |
.99 |
1.04 |
1.01 |
.99 |
1.00 |
| KLA/ATP | .98 |
1.03 |
.93 |
.96 |
.99 |
1.08 |
1.02 |
|
Comt |  |
NM_007744 |
catechol-O-methyltransferase (Comt), transcript variant 2, mRNA [NM_007744] |
KLA | .46 |
.45 |
.42 |
.38 |
.37 |
.38 |
.50 |
| ATP | .91 |
.90 |
.89 |
.84 |
.73 |
.38 |
.72 |
| KLA/ATP | .44 |
.44 |
.43 |
.37 |
.39 |
.31 |
.32 |
|
Cyp11a1 |  |
NM_019779 |
cytochrome P450, family 11, subfamily a, polypeptide 1 (Cyp11a1), nuclear gene encoding mitochondrial protein, mRNA [NM_019779] |
KLA | 1.03 |
1.00 |
.96 |
1.04 |
1.05 |
1.03 |
.97 |
| ATP | 1.00 |
.99 |
.99 |
1.02 |
1.04 |
1.00 |
.99 |
| KLA/ATP | .99 |
1.03 |
1.05 |
.98 |
.95 |
.95 |
.96 |
|
Cyp11b2 |  |
NM_009991 |
cytochrome P450, family 11, subfamily b, polypeptide 2 (Cyp11b2), nuclear gene encoding mitochondrial protein, mRNA [NM_009991] |
KLA | .93 |
1.00 |
1.03 |
1.05 |
1.04 |
1.09 |
1.03 |
| ATP | 1.01 |
1.00 |
1.02 |
1.11 |
.99 |
1.02 |
1.01 |
| KLA/ATP | 1.03 |
.98 |
.84 |
1.10 |
1.05 |
1.38 |
.98 |
|
Cyp17a1 |  |
NM_007809 |
cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), mRNA [NM_007809] |
KLA | 1.55 |
1.60 |
1.71 |
1.73 |
1.51 |
1.58 |
1.18 |
| ATP | .94 |
1.01 |
1.27 |
1.44 |
1.39 |
1.36 |
1.11 |
| KLA/ATP | 1.48 |
1.79 |
1.95 |
2.05 |
1.92 |
1.75 |
1.56 |
|
Cyp19a1 |  |
NM_007810 |
cytochrome P450, family 19, subfamily a, polypeptide 1 (Cyp19a1), mRNA [NM_007810] |
KLA | 1.04 |
.97 |
1.05 |
1.03 |
.99 |
1.02 |
.98 |
| ATP | 1.00 |
1.02 |
1.00 |
.93 |
.97 |
.99 |
1.08 |
| KLA/ATP | .99 |
.99 |
1.07 |
1.02 |
.98 |
.97 |
.98 |
|
Cyp1a1 |  |
NM_009992 |
cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992] |
KLA | 1.07 |
.99 |
1.02 |
1.01 |
1.00 |
1.00 |
1.11 |
| ATP | .99 |
1.02 |
1.01 |
.95 |
.96 |
.94 |
1.09 |
| KLA/ATP | 1.01 |
1.03 |
.98 |
.96 |
.96 |
.95 |
1.51 |
|
Cyp1b1 |  |
AK016699 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4933406K16 product:cytochrome P450, 1b1, benz[a]anthracene inducible, full insert sequence. [AK016699] |
KLA | 1.00 |
1.03 |
1.00 |
1.02 |
1.02 |
.97 |
1.03 |
| ATP | 1.00 |
1.04 |
1.03 |
1.13 |
1.04 |
1.05 |
1.02 |
| KLA/ATP | 1.06 |
1.03 |
.96 |
1.05 |
1.07 |
1.12 |
1.09 |
|
Cyp1b1 |  |
NM_009994 |
cytochrome P450, family 1, subfamily b, polypeptide 1 (Cyp1b1), mRNA [NM_009994] |
KLA | 1.02 |
.99 |
1.04 |
1.05 |
.98 |
1.00 |
1.07 |
| ATP | 1.05 |
1.01 |
1.05 |
1.19 |
1.09 |
2.31 |
5.32 |
| KLA/ATP | .99 |
1.02 |
1.05 |
1.06 |
1.14 |
1.39 |
3.15 |
|
Cyp21a1 |  |
NM_009995 |
cytochrome P450, family 21, subfamily a, polypeptide 1 (Cyp21a1), mRNA [NM_009995] |
KLA | .96 |
1.04 |
.98 |
1.05 |
1.00 |
.98 |
1.03 |
| ATP | 1.02 |
.93 |
1.02 |
1.11 |
1.03 |
1.04 |
1.10 |
| KLA/ATP | .91 |
1.00 |
1.02 |
1.01 |
1.04 |
.90 |
1.00 |
|
Cyp3a11 |  |
NM_007818 |
cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818] |
KLA | .96 |
.94 |
1.06 |
1.04 |
.96 |
.94 |
.97 |
| ATP | 1.00 |
1.01 |
.94 |
.95 |
.94 |
.92 |
.98 |
| KLA/ATP | .98 |
1.06 |
1.06 |
.98 |
.88 |
.93 |
.91 |
|
Cyp3a13 |  |
NM_007819 |
cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819] |
KLA | .99 |
.98 |
.98 |
1.03 |
.97 |
1.01 |
1.07 |
| ATP | 1.00 |
1.01 |
1.01 |
1.04 |
1.01 |
.99 |
1.00 |
| KLA/ATP | 1.06 |
1.01 |
1.00 |
1.08 |
1.09 |
1.01 |
1.09 |
|
Cyp3a16 |  |
NM_007820 |
cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820] |
KLA | .95 |
.99 |
.96 |
.96 |
1.00 |
1.03 |
.99 |
| ATP | 1.04 |
1.03 |
.98 |
.97 |
.98 |
1.03 |
1.01 |
| KLA/ATP | .96 |
.91 |
.96 |
.97 |
1.03 |
1.00 |
1.04 |
|
Cyp3a25 |  |
NM_019792 |
cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792] |
KLA | 1.00 |
.96 |
1.01 |
1.04 |
.99 |
.99 |
1.01 |
| ATP | 1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.93 |
.95 |
| KLA/ATP | .97 |
1.09 |
1.04 |
1.01 |
.99 |
.97 |
.97 |
|
Cyp3a41a
|  |
NM_017396 |
cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396] |
KLA | 1.02 |
.99 |
.98 |
.95 |
.93 |
.93 |
1.06 |
| ATP | 1.00 |
.96 |
1.02 |
.97 |
.97 |
.95 |
1.02 |
| KLA/ATP | 1.03 |
1.02 |
1.07 |
.97 |
.93 |
.97 |
.97 |
|
Cyp3a44 |  |
NM_177380 |
cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380] |
KLA | 1.05 |
1.03 |
1.05 |
1.02 |
1.08 |
1.00 |
1.03 |
| ATP | .97 |
1.00 |
1.03 |
1.07 |
.99 |
.99 |
.99 |
| KLA/ATP | 1.04 |
.99 |
.99 |
1.06 |
1.04 |
1.06 |
1.00 |
|
Cyp7a1 |  |
NM_007824 |
cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1), mRNA [NM_007824] |
KLA | 1.03 |
.99 |
.97 |
1.00 |
.97 |
1.03 |
.99 |
| ATP | .99 |
.99 |
1.02 |
1.04 |
.99 |
.99 |
1.03 |
| KLA/ATP | 1.03 |
1.00 |
.99 |
.99 |
.91 |
.97 |
.99 |
|
Cyp7b1 |  |
NM_007825 |
cytochrome P450, family 7, subfamily b, polypeptide 1 (Cyp7b1), mRNA [NM_007825] |
KLA | 1.16 |
1.20 |
1.26 |
1.21 |
1.10 |
1.05 |
1.07 |
| ATP | 1.06 |
1.02 |
1.01 |
.95 |
.99 |
1.00 |
.98 |
| KLA/ATP | 1.27 |
1.31 |
1.24 |
1.13 |
1.16 |
1.10 |
1.03 |
|
H2-Ke6 |  |
NM_013543 |
H2-K region expressed gene 6 (H2-Ke6), mRNA [NM_013543] |
KLA | 1.00 |
1.03 |
.95 |
.96 |
.88 |
.79 |
.63 |
| ATP | .96 |
1.01 |
.98 |
1.44 |
1.13 |
.66 |
.59 |
| KLA/ATP | .99 |
1.08 |
1.19 |
1.48 |
1.19 |
.73 |
.49 |
|
Hsd11b1 |  |
NM_008288 |
hydroxysteroid 11-beta dehydrogenase 1 (Hsd11b1), transcript variant 1, mRNA [NM_008288] |
KLA | 1.02 |
1.05 |
1.08 |
1.06 |
1.17 |
1.25 |
2.06 |
| ATP | 1.06 |
1.08 |
1.05 |
1.15 |
1.10 |
1.21 |
1.70 |
| KLA/ATP | 1.09 |
1.13 |
1.12 |
1.11 |
1.15 |
1.21 |
1.71 |
|
Hsd11b2 |  |
NM_008289 |
hydroxysteroid 11-beta dehydrogenase 2 (Hsd11b2), mRNA [NM_008289] |
KLA | 1.06 |
1.09 |
1.02 |
1.09 |
1.03 |
1.06 |
1.09 |
| ATP | 1.02 |
1.07 |
1.13 |
1.08 |
.93 |
1.01 |
1.05 |
| KLA/ATP | 1.07 |
1.04 |
.98 |
1.04 |
1.12 |
1.00 |
1.03 |
|
Hsd17b1 |  |
NM_010475 |
hydroxysteroid (17-beta) dehydrogenase 1 (Hsd17b1), mRNA [NM_010475] |
KLA | .85 |
.93 |
.83 |
.86 |
.82 |
.84 |
.92 |
| ATP | 1.11 |
1.11 |
1.02 |
1.96 |
1.92 |
1.07 |
.99 |
| KLA/ATP | .88 |
.92 |
.89 |
1.56 |
2.01 |
1.13 |
1.34 |
|
Hsd17b12
|  |
AK076088 |
10, 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2810004A21 product:hydroxysteroid (17-beta) dehydrogenase 12, full insert sequence. [AK076088] |
KLA | 1.03 |
.87 |
.97 |
1.11 |
1.17 |
1.00 |
1.15 |
| ATP | 1.03 |
1.11 |
1.81 |
1.27 |
1.57 |
1.18 |
1.14 |
| KLA/ATP | 1.00 |
.90 |
1.26 |
.97 |
1.03 |
.97 |
.98 |
|
Hsd17b12
|  |
NM_019657 |
hydroxysteroid (17-beta) dehydrogenase 12 (Hsd17b12), mRNA [NM_019657] |
KLA | 1.12 |
1.30 |
1.47 |
1.16 |
1.07 |
1.34 |
1.20 |
| ATP | 1.01 |
1.28 |
1.28 |
1.14 |
1.06 |
1.05 |
.93 |
| KLA/ATP | 1.21 |
1.44 |
1.63 |
1.51 |
.91 |
.81 |
.87 |
|
Hsd17b2 |  |
NM_008290 |
hydroxysteroid (17-beta) dehydrogenase 2 (Hsd17b2), mRNA [NM_008290] |
KLA | .99 |
1.05 |
.95 |
1.05 |
1.04 |
1.04 |
.97 |
| ATP | 1.03 |
.98 |
.98 |
1.03 |
.97 |
.99 |
1.06 |
| KLA/ATP | 1.10 |
1.01 |
1.01 |
1.03 |
1.02 |
.97 |
1.03 |
|
Hsd17b3 |  |
NM_008291 |
hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3), mRNA [NM_008291] |
KLA | .99 |
.93 |
.99 |
1.04 |
.96 |
1.00 |
.96 |
| ATP | 1.01 |
.98 |
.98 |
.95 |
.98 |
1.01 |
.98 |
| KLA/ATP | .96 |
1.07 |
.99 |
.96 |
.91 |
.95 |
.94 |
|
Hsd17b6 |  |
NM_013786 |
hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), mRNA [NM_013786] |
KLA | .97 |
1.03 |
.99 |
1.00 |
1.02 |
.96 |
1.02 |
| ATP | .96 |
1.04 |
.94 |
.97 |
.97 |
1.04 |
1.01 |
| KLA/ATP | .89 |
.99 |
1.03 |
.94 |
.98 |
.98 |
.95 |
|
Hsd17b7 |  |
NM_010476 |
hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7), mRNA [NM_010476] |
KLA | .87 |
.86 |
.78 |
.85 |
.86 |
.76 |
.77 |
| ATP | 1.05 |
.94 |
1.22 |
.87 |
.69 |
.67 |
1.48 |
| KLA/ATP | .88 |
.76 |
.91 |
.70 |
.53 |
.34 |
.36 |
|
Hsd3b1 |  |
NM_008293 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (Hsd3b1), mRNA [NM_008293] |
KLA | .98 |
.97 |
.93 |
.92 |
1.00 |
.98 |
.95 |
| ATP | .93 |
1.01 |
1.00 |
1.04 |
.94 |
1.01 |
.88 |
| KLA/ATP | 1.01 |
.92 |
1.06 |
.98 |
1.03 |
.95 |
.97 |
|
Hsd3b2 |  |
ENSMUST00000107022 |
ens|3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3- beta-HSD II) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (E |
KLA | 1.06 |
.89 |
.93 |
.99 |
1.00 |
1.03 |
.96 |
| ATP | .94 |
1.03 |
.96 |
.91 |
.94 |
1.01 |
.93 |
| KLA/ATP | .93 |
1.01 |
.99 |
1.02 |
1.00 |
1.05 |
1.01 |
|
Hsd3b2 |  |
NM_153193 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 (Hsd3b2), mRNA [NM_153193] |
KLA | 1.00 |
.99 |
1.00 |
1.05 |
.97 |
1.00 |
1.07 |
| ATP | .99 |
.99 |
.97 |
1.07 |
1.02 |
.99 |
1.01 |
| KLA/ATP | 1.02 |
1.07 |
.96 |
.98 |
1.02 |
1.08 |
.98 |
|
Hsd3b4 |  |
NM_001111336 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 1, mRNA [NM_001111336] |
KLA | 1.01 |
1.03 |
.98 |
1.02 |
1.03 |
1.00 |
.92 |
| ATP | 1.06 |
1.06 |
1.03 |
.94 |
1.06 |
.96 |
.97 |
| KLA/ATP | 1.04 |
1.04 |
1.10 |
.94 |
.94 |
.98 |
.97 |
|
Hsd3b4 |  |
NM_008294 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 (Hsd3b4), transcript variant 2, mRNA [NM_008294] |
KLA | 1.06 |
1.09 |
1.11 |
1.13 |
1.04 |
1.13 |
1.12 |
| ATP | 1.00 |
.96 |
1.24 |
1.06 |
1.11 |
1.04 |
1.12 |
| KLA/ATP | 1.06 |
1.05 |
1.15 |
1.15 |
1.16 |
1.14 |
1.12 |
|
Hsd3b5 |  |
NM_008295 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 5 (Hsd3b5), mRNA [NM_008295] |
KLA | 1.00 |
.97 |
1.10 |
.92 |
.98 |
1.05 |
1.09 |
| ATP | 1.02 |
.95 |
.99 |
.95 |
.97 |
.93 |
.99 |
| KLA/ATP | .96 |
1.06 |
1.01 |
1.03 |
1.02 |
1.00 |
1.00 |
|
Hsd3b6 |  |
NM_013821 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 6 (Hsd3b6), mRNA [NM_013821] |
KLA | 1.06 |
1.09 |
1.05 |
1.02 |
.98 |
1.09 |
1.04 |
| ATP | 1.03 |
.96 |
1.05 |
1.01 |
1.02 |
1.00 |
1.04 |
| KLA/ATP | 1.02 |
1.02 |
1.06 |
1.03 |
1.04 |
1.14 |
1.06 |
|
Mm.18893 9 |  |
6754247 |
Unknown |
KLA | .71 |
.85 |
.76 |
.78 |
.76 |
.81 |
.90 |
| ATP | 1.13 |
1.21 |
1.21 |
2.93 |
3.64 |
1.24 |
.96 |
| KLA/ATP | .77 |
.82 |
.96 |
2.56 |
4.66 |
1.65 |
1.50 |
|
Mm.26719
|  |
23680951 |
Unknown |
KLA | .97 |
.96 |
.93 |
1.05 |
.94 |
1.09 |
.99 |
| ATP | .96 |
1.00 |
1.02 |
1.02 |
1.01 |
1.04 |
.94 |
| KLA/ATP | 1.13 |
1.02 |
.97 |
1.00 |
1.09 |
1.05 |
1.08 |
|
Mm.30009 5 |  |
145699117 |
Unknown |
KLA | .70 |
.74 |
.85 |
.84 |
.90 |
.85 |
.90 |
| ATP | .83 |
.77 |
.93 |
.98 |
1.05 |
1.04 |
.86 |
| KLA/ATP | .72 |
.70 |
.86 |
.97 |
1.13 |
.80 |
.83 |
|
Mm.32260 6 |  |
141803200 |
Unknown |
KLA | .95 |
.95 |
.98 |
1.03 |
.96 |
.93 |
1.00 |
| ATP | 1.02 |
1.05 |
.97 |
.99 |
1.02 |
.98 |
.99 |
| KLA/ATP | .96 |
1.16 |
1.01 |
.88 |
1.02 |
1.05 |
1.00 |
|
Mm.32260 6 |  |
94411982 |
Unknown |
KLA | 1.00 |
1.02 |
1.09 |
1.05 |
1.08 |
1.11 |
1.07 |
| ATP | 1.01 |
.95 |
1.05 |
1.08 |
.97 |
.94 |
1.06 |
| KLA/ATP | .96 |
.98 |
1.10 |
1.08 |
.99 |
1.00 |
1.04 |
|
Mm.42301 1 |  |
94421068 |
Unknown |
KLA | 1.06 |
1.06 |
1.07 |
1.09 |
1.06 |
1.17 |
1.05 |
| ATP | .99 |
1.00 |
1.36 |
1.47 |
1.55 |
2.49 |
3.48 |
| KLA/ATP | 1.08 |
1.08 |
1.22 |
1.23 |
1.31 |
1.75 |
3.23 |
|
Mm.46685 9 |  |
145699102 |
Unknown |
KLA | .65 |
.64 |
.75 |
.87 |
.83 |
.79 |
.82 |
| ATP | .80 |
.77 |
.97 |
.86 |
1.13 |
1.05 |
.85 |
| KLA/ATP | .64 |
.65 |
.85 |
.86 |
1.16 |
.69 |
.72 |
|
Srd5a1 |  |
AK019597 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930435F02 product:similar to 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE 1 (EC 1.3.99.5) (STEROID 5-ALPHA-REDUCTASE 1) (SR TYPE 1) [Rattus norvegicus], full insert sequence [AK0 |
KLA | .91 |
.93 |
1.01 |
.89 |
.99 |
1.03 |
.97 |
| ATP | .92 |
.93 |
.94 |
1.03 |
1.01 |
.99 |
.99 |
| KLA/ATP | .94 |
.99 |
1.04 |
1.05 |
1.06 |
1.17 |
.93 |
|
Srd5a1 |  |
NM_175283 |
steroid 5 alpha-reductase 1 (Srd5a1), mRNA [NM_175283] |
KLA | .91 |
.76 |
.78 |
.78 |
.55 |
.55 |
.55 |
| ATP | .99 |
.91 |
1.36 |
1.21 |
.97 |
1.19 |
.77 |
| KLA/ATP | .80 |
.78 |
1.01 |
.85 |
.91 |
.93 |
.68 |
|
Srd5a2 |  |
NM_053188 |
steroid 5 alpha-reductase 2 (Srd5a2), mRNA [NM_053188] |
KLA | 1.01 |
1.01 |
1.02 |
1.02 |
.98 |
1.00 |
1.02 |
| ATP | 1.01 |
.92 |
1.04 |
1.07 |
1.01 |
1.02 |
.94 |
| KLA/ATP | 1.04 |
1.02 |
1.03 |
1.02 |
.98 |
1.16 |
1.01 |
|
Srd5a3 |  |
NM_020611 |
steroid 5 alpha-reductase 3 (Srd5a3), mRNA [NM_020611] |
KLA | 1.14 |
1.16 |
1.13 |
1.40 |
1.50 |
1.45 |
1.52 |
| ATP | 1.12 |
1.13 |
1.09 |
1.17 |
1.15 |
.93 |
1.38 |
| KLA/ATP | 1.11 |
1.21 |
1.35 |
1.28 |
1.11 |
1.01 |
1.52 |
|
Sts |  |
NM_009293 |
steroid sulfatase (Sts), mRNA [NM_009293] |
KLA | .89 |
.99 |
1.08 |
.82 |
.86 |
.70 |
.77 |
| ATP | 1.16 |
1.51 |
1.04 |
3.22 |
3.12 |
2.91 |
2.15 |
| KLA/ATP | 1.19 |
1.24 |
.66 |
2.22 |
1.82 |
3.02 |
3.22 |
|
Sult1e1 |  |
NM_023135 |
sulfotransferase family 1E, member 1 (Sult1e1), mRNA [NM_023135] |
KLA | .98 |
1.00 |
1.01 |
1.03 |
.98 |
1.02 |
1.05 |
| ATP | 1.03 |
.99 |
1.05 |
1.06 |
1.00 |
.94 |
1.04 |
| KLA/ATP | 1.00 |
.99 |
.92 |
.97 |
.98 |
1.00 |
.96 |
|
Sult2b1 |  |
NM_017465 |
sulfotransferase family, cytosolic, 2B, member 1 (Sult2b1), mRNA [NM_017465] |
KLA | .99 |
.94 |
.94 |
.97 |
.97 |
.94 |
.91 |
| ATP | .95 |
1.02 |
.99 |
.98 |
1.07 |
1.07 |
.94 |
| KLA/ATP | .91 |
1.00 |
1.03 |
.94 |
1.06 |
1.23 |
1.06 |
|
Ugt1a1 |  |
NM_201645 |
UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1), mRNA [NM_201645] |
KLA | .95 |
1.07 |
1.00 |
.99 |
.97 |
.98 |
1.02 |
| ATP | 1.08 |
.95 |
1.02 |
1.04 |
1.08 |
1.03 |
1.01 |
| KLA/ATP | 1.02 |
.95 |
.93 |
1.01 |
1.01 |
1.11 |
1.06 |
|
Ugt1a6b |  |
NM_201410 |
UDP glucuronosyltransferase 1 family, polypeptide A6B (Ugt1a6b), mRNA [NM_201410] |
KLA | .89 |
.86 |
.93 |
.93 |
.89 |
.86 |
.89 |
| ATP | 1.10 |
1.05 |
1.15 |
1.07 |
1.01 |
.99 |
1.24 |
| KLA/ATP | .90 |
.94 |
1.02 |
.89 |
.87 |
.81 |
.92 |
|
Ugt1a9 |  |
NM_201644 |
UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), mRNA [NM_201644] |
KLA | 1.07 |
.96 |
.98 |
1.09 |
1.03 |
1.06 |
1.08 |
| ATP | 1.04 |
.94 |
1.01 |
1.07 |
1.05 |
1.02 |
1.06 |
| KLA/ATP | 1.05 |
1.00 |
.94 |
1.01 |
1.03 |
1.04 |
1.00 |
|
Ugt2a1 |  |
NM_053184 |
UDP glucuronosyltransferase 2 family, polypeptide A1 (Ugt2a1), mRNA [NM_053184] |
KLA | 1.01 |
1.03 |
.99 |
.99 |
.99 |
1.01 |
1.02 |
| ATP | 1.01 |
.93 |
1.04 |
1.03 |
1.02 |
1.01 |
1.03 |
| KLA/ATP | 1.04 |
1.01 |
1.01 |
1.02 |
1.01 |
1.02 |
1.00 |
|
Ugt2a3 |  |
NM_028094 |
UDP glucuronosyltransferase 2 family, polypeptide A3 (Ugt2a3), mRNA [NM_028094] |
KLA | 1.07 |
1.01 |
.97 |
1.05 |
1.01 |
.98 |
.99 |
| ATP | .98 |
.96 |
1.04 |
1.06 |
.95 |
.94 |
1.01 |
| KLA/ATP | 1.02 |
1.00 |
.94 |
1.02 |
1.02 |
1.01 |
1.06 |
|
Ugt2b1 |  |
NM_152811 |
UDP glucuronosyltransferase 2 family, polypeptide B1 (Ugt2b1), mRNA [NM_152811] |
KLA | 1.08 |
1.01 |
.95 |
1.08 |
1.00 |
1.04 |
.97 |
| ATP | 1.03 |
1.14 |
1.01 |
1.00 |
1.01 |
1.05 |
1.13 |
| KLA/ATP | 1.05 |
.99 |
1.06 |
.98 |
1.03 |
.96 |
.98 |
|
Ugt2b34 |  |
NM_153598 |
UDP glucuronosyltransferase 2 family, polypeptide B34 (Ugt2b34), mRNA [NM_153598] |
KLA | .98 |
1.08 |
.99 |
1.06 |
.97 |
1.05 |
1.03 |
| ATP | 1.06 |
1.04 |
.96 |
1.01 |
1.03 |
1.01 |
.99 |
| KLA/ATP | 1.09 |
.94 |
1.00 |
1.07 |
1.01 |
1.03 |
.97 |
|
Ugt2b35 |  |
NM_172881 |
UDP glucuronosyltransferase 2 family, polypeptide B35 (Ugt2b35), mRNA [NM_172881] |
KLA | .99 |
1.02 |
.99 |
1.01 |
1.00 |
.96 |
1.01 |
| ATP | .96 |
1.02 |
1.02 |
.96 |
.93 |
1.00 |
1.02 |
| KLA/ATP | 1.01 |
.99 |
1.04 |
1.00 |
.97 |
.93 |
.97 |
|
Ugt2b36 |  |
NM_001029867 |
UDP glucuronosyltransferase 2 family, polypeptide B36 (Ugt2b36), mRNA [NM_001029867] |
KLA | .95 |
.95 |
1.00 |
1.00 |
1.03 |
1.02 |
.92 |
| ATP | 1.02 |
1.07 |
1.03 |
.95 |
1.01 |
.93 |
1.00 |
| KLA/ATP | .99 |
1.05 |
.98 |
1.04 |
1.02 |
.98 |
.99 |
|
Ugt2b37 |  |
NM_053215 |
UDP glucuronosyltransferase 2 family, polypeptide B37 (Ugt2b37), mRNA [NM_053215] |
KLA | 1.02 |
1.06 |
1.04 |
1.05 |
1.00 |
1.05 |
1.03 |
| ATP | 1.01 |
1.03 |
1.08 |
1.01 |
1.05 |
1.02 |
1.05 |
| KLA/ATP | 1.01 |
.99 |
1.11 |
1.14 |
1.04 |
1.08 |
1.05 |
|
Ugt2b38 |  |
NM_133894 |
UDP glucuronosyltransferase 2 family, polypeptide B38 (Ugt2b38), mRNA [NM_133894] |
KLA | 1.00 |
.96 |
1.04 |
.99 |
1.10 |
.97 |
.99 |
| ATP | 1.02 |
1.04 |
1.03 |
.94 |
.96 |
.93 |
.99 |
| KLA/ATP | .98 |
.97 |
1.00 |
.97 |
.98 |
1.04 |
1.02 |
|
Ugt2b5 |  |
NM_009467 |
UDP glucuronosyltransferase 2 family, polypeptide B5 (Ugt2b5), mRNA [NM_009467] |
KLA | 1.01 |
.99 |
1.09 |
.96 |
.97 |
.99 |
1.01 |
| ATP | 1.03 |
1.02 |
1.02 |
1.01 |
.97 |
.90 |
.94 |
| KLA/ATP | .99 |
.99 |
.98 |
1.05 |
1.01 |
.93 |
.95 |
|